Delivery Order SPE2DB20D9332-SPE2DB23FV3D1

Award Date 8/18/23
Potential Completion Date 8/21/23
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,373.08 firm fixed-price delivery order is for the supply of the prescription drug Aubagio 14 mg tablets. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which allows the DLA to issue firm...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $4,675.52, is for the provision of Aubagio 14 mg tablets (30 count) to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
This contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was issued by the Defense Logistics Agency (DLA) on July 7, 2022. The $14,026.56 firm fixed-price delivery order contract is for the provision of 4557730469 AUBAGIO 14 MG TABLET 30S, a specialized pharmaceutical product, to support the medical supply needs of military healthcare facilities. The award is part of DMS Pharmaceutical Group's larger...
This firm fixed-price delivery order worth $7,013.28 was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of the pharmaceutical product AUBAGIO 7 MG TABLET 30S. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue firm fixed-price delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $14,059.68, is for the supply of Aubagio 14 mg tablets. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is for the delivery of a pharmaceutical product called AUBAGIO 14 MG TABLET 30S. The contract award has a ceiling value of $14,026.62 and is a firm fixed-price delivery order with no set-aside designation. The contract is part of a larger indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) under the SPE2DB program, valued at up to $499,999,999 and running...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,337.76 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4,566,340,512 units of the pharmaceutical product Aubagio 14 mg tablets. This delivery order is issued under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which covers a wide range of branded and generic prescription...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,686.56 firm fixed-price delivery order is for the pharmaceutical product AUBAGIO 7 MG TABLET 30S. This award is under a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA, which enables the DLA to issue delivery orders for a comprehensive range...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,337.76 award is for the supply of the prescription drug Aubagio 7 mg tablets, with a completion date of July 3, 2023. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue firm...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $11,716.35, is for the delivery of the prescription drug Aubagio 14 mg tablet, with an ultimate completion date of August 30, 2021. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
  • SPE2DB20D9332
    Indefinite Delivery Contract
  • SPE2DB20D9332-SPE2DB23FV3D1
    Delivery Order

This federal contract award, valued at $14,026.56, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of Aubagio 14 mg tablets to support the medical needs of military healthcare facilities.

DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to sustain the medical supply requirements of Department of Defense healthcare sites worldwide. The contract does not have a set-aside designation, allowing DMS Pharmaceutical Group Inc. to leverage its woman-owned small business status to secure direct federal awards across multiple product categories and medical domains.

Generated 2/27/25, 11:29 AM